Beijing InnoCare Pharma Tech Co., Ltd.

Works in Dermatology · Genetic & rare · GI & liver · Hematology · Immunology · Neurology · Oncology · Respiratory

Beijing InnoCare Pharma Tech Co., Ltd. is a clinical trial sponsor. It has 29 active clinical trials with 6,912 planned participants, across 8 therapeutic areas. Since 2021 it has completed 10 trials and stopped 0 early.

Trial track record · since 2021

29Active trials6,912 planned participants
10Completed0 with results posted
0Stopped early0% of finished trials

Pipeline · 29 active trials

StageTrialStatus

Questions about Beijing InnoCare Pharma Tech Co., Ltd

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-05.

Approve Suite is not affiliated with Beijing InnoCare Pharma Tech Co., Ltd..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.